Moleculin Biotech Inc (MBRX)

Aug 18, 2025

Moleculin Biotech Releases New Corporate Presentation - TipRanks

Aug 18, 2025

Aug 18, 2025

Statistical indicators supporting Moleculin Biotech Inc.’s strengthJuly 2025 Trends & Growth Oriented Trade Recommendations - Newser

Aug 18, 2025

Aug 18, 2025

Using Bollinger Bands to evaluate Moleculin Biotech Inc.Earnings Overview Summary & Community Consensus Picks - Newser

Aug 18, 2025

Aug 17, 2025

Will Moleculin Biotech Inc. stock recover after recent drop2025 Market Overview & Smart Allocation Stock Reports - Newser

Aug 17, 2025

Aug 17, 2025

Custom watchlist performance reports with Moleculin Biotech Inc.July 2025 Snapshot & Capital Efficient Trading Techniques - Newser

Aug 17, 2025

Aug 17, 2025

Using RSI to spot recovery in Moleculin Biotech Inc.July 2025 Earnings & Trade Opportunity Analysis Reports - Newser

Aug 17, 2025

Aug 17, 2025

What’s the recovery path for long term holders of Moleculin Biotech Inc.Recession Risk & Safe Entry Point Identification - Newser

Aug 17, 2025

Aug 17, 2025

Has Moleculin Biotech Inc. Stock Ever Crashed Historical Volatility ReviewShare Buyback & Consistent Income Trade Recommendations - Newser

Aug 17, 2025

Aug 16, 2025

Is Moleculin Biotech Inc. forming a breakout patternJuly 2025 Drop Watch & Real-Time Market Trend Scan - thegnnews.com

Aug 16, 2025

Aug 16, 2025

HC Wainwright Has Positive Estimate for MBRX Q3 Earnings - Defense World

Aug 16, 2025

Aug 16, 2025

How to use Fibonacci retracement on Moleculin Biotech Inc.Market Risk Summary & Safe Entry Trade Signal Reports - Newser

Aug 16, 2025

Aug 16, 2025

Using AI based signals to follow Moleculin Biotech Inc.2025 Top Decliners & Long-Term Safe Investment Plans - Newser

Aug 16, 2025

Aug 16, 2025

What’s the outlook for Moleculin Biotech Inc.’s sectorJuly 2025 Opening Moves & Risk Controlled Stock Pick Alerts - thegnnews.com

Aug 16, 2025

Aug 16, 2025

Applying Elliott Wave Theory to Moleculin Biotech Inc.2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - Newser

Aug 16, 2025

Aug 16, 2025

Combining price and volume data for Moleculin Biotech Inc.Market Weekly Review & Target Return Focused Picks - Newser

Aug 16, 2025

Aug 15, 2025

Is Moleculin Biotech Inc. stock bottoming outJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - Newser

Aug 15, 2025

Aug 15, 2025

Does Moleculin Biotech Inc. fit your quant trading modelJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser

Aug 15, 2025

Aug 15, 2025

Is Moleculin Biotech Inc. stock a buy or sellJuly 2025 Selloffs & Short-Term Trading Opportunity Alerts - thegnnews.com

Aug 15, 2025

Aug 15, 2025

Webull Corporation shares rise 1.49% premarket after AIM ImmunoTech and Moleculin Biotech to present at Webull Financial Corporate Connect Webinar Series. - AInvest

Aug 15, 2025

Aug 14, 2025

Moleculin Biotech reports Q2 EPS (49c) vs. ($1.70) last year - MSN

Aug 14, 2025

Aug 14, 2025

Moleculin receives notice of intent to grant new European patent for Annamycin - MSN

Aug 14, 2025

Aug 14, 2025

Moleculin Biotech Misses Fiscal Q2 EPS - AOL.com

Aug 14, 2025

Aug 14, 2025

Moleculin Biotech to present at Webull Financial Corporate Connect webinar series - AInvest

Aug 14, 2025

Aug 14, 2025

Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - GlobeNewswire

Aug 14, 2025

Aug 14, 2025

Late-Stage Cancer Drug Developer Moleculin Showcases Pipeline at Webull Healthcare Event - Stock Titan

Aug 14, 2025

Aug 14, 2025

Moleculin Biotech Reports Q2 2025 Financial Results - MSN

Aug 14, 2025

Aug 13, 2025

Moleculin Reports Second Quarter 2025 Financial Results and Highlights - GlobeNewswire

Aug 13, 2025

Aug 13, 2025

Moleculin Biotech Inc's Q2 2025 EPS Falls Short of Analyst Estimates, Annamycin Program Advances Amid Financial Challenges - AInvest

Aug 13, 2025

Aug 13, 2025

Moleculin Biotech: A High-Risk, High-Reward Play in Oncology Innovation Amid Capital Constraints - AInvest

Aug 13, 2025

Aug 13, 2025

Moleculin's Cancer Drug Trial Grows Globally as Critical Data Readout Approaches in 2025 - Stock Titan

Aug 13, 2025

Aug 13, 2025

Promising Developments in Annamycin Drive Buy Rating for Moleculin Biotech - TipRanks

Aug 13, 2025

Aug 13, 2025

How liquid is Moleculin Biotech Inc. stockJuly 2025 Final Week & Verified Chart Pattern Signals - newsyoung.net

Aug 13, 2025

Aug 10, 2025

Moleculin Biotech (MBRX) Projected to Post Quarterly Earnings on Tuesday - Defense World

Aug 10, 2025

Aug 09, 2025

Moleculin Biotech MBRX 2025Q2 Earnings Preview Upside Potential Driven by Strategic Developments - AInvest

Aug 09, 2025

Aug 09, 2025

Short Interest in Moleculin Biotech, Inc. (NASDAQ:MBRX) Grows By 52.0% - Defense World

Aug 09, 2025

Aug 08, 2025

Heatmap analysis for Moleculin Biotech Inc. and competitorsMomentum Trend Signal Weekly Recap Summary - Newser

Aug 08, 2025

Aug 07, 2025

Moleculin Biotech shares rise 3.66% premarket after unveiling promising preclinical data for Annamycin. - AInvest

Aug 07, 2025

Aug 06, 2025

Moleculin Biotech shares fall 5.11% intraday despite promising preclinical data for Annamycin. - AInvest

Aug 06, 2025

Aug 06, 2025

Moleculin Biotech announces preclinical data of annamycin in liver cancer - TipRanks

Aug 06, 2025

Aug 06, 2025

Moleculin Biotech Reveals Promising Preclinical Data for Annamycin - TipRanks

Aug 06, 2025

Aug 06, 2025

Moleculin Biotech Highlights Annamycin's Potential Against Liver Cancers with Promising Preclinical Data - Quiver Quantitative

Aug 06, 2025

Aug 06, 2025

Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment - GlobeNewswire

Aug 06, 2025

Aug 06, 2025

Revolutionary Cancer Treatment: Moleculin's Annamycin Targets 3 Types of Liver Cancer Without Heart Risks - Stock Titan

Aug 06, 2025

Aug 06, 2025

Moleculin Biotech shares rise 5.55% intraday after unveiling promising preclinical data for Annamycin. - AInvest

Aug 06, 2025

Aug 03, 2025

What is Moleculin Biotech Inc. company’s growth strategyMaximize returns with expert trading insights - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Moleculin Biotech Inc. a good long term investmentAchieve unparalleled market performance - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Moleculin Biotech Inc. compare to its industry peersInvest smarter with high-probability setups - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is it the right time to buy Moleculin Biotech Inc. stockUnlock real-time trading signals for gains - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Moleculin Biotech Inc. stock price move sharplyBuild a diversified portfolio for steady profits - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Moleculin Biotech Releases Corporate Presentation Update - AInvest

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Moleculin Biotech Inc.Capitalize on emerging trends for profits - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Moleculin Biotech Inc. stock higher in 2025Robust financial gains - Jammu Links News

Aug 03, 2025

Aug 02, 2025

How volatile is Moleculin Biotech Inc. stock compared to the marketFree Stock Market Forecast Reports - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How strong is Moleculin Biotech Inc. company’s balance sheetFree Stock Market Mentorship - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Moleculin Biotech Inc. Ranks High in Smart Money TrackerROI Driven Equity Selection With Safety Emphasized - metal.it

Aug 01, 2025

Aug 01, 2025

Why Moleculin Biotech Inc. stock attracts strong analyst attentionPattern Breakout Tracker with Screener Tools - Newser

Aug 01, 2025